Sunitinib malate and Claritin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sunitinib malate (sunitinib malate) and Claritin (loratadine). Common drug interactions include hyponatraemia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Sunitinib malate and Claritin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Sunitinib malate?

Sunitinib malate has active ingredients of sunitinib malate. eHealthMe is studying from 9,160 Sunitinib malate users. Check the latest studies of Sunitinib malate.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,315 Claritin users. Check the latest studies of Claritin.

On Jul, 11, 2026

13 people who take Sunitinib malate and Claritin together, and have interactions are studied.

Sunitinib malate and Claritin drug interactions.

What are the common drug interactions of Sunitinib Malate and Claritin, by gender? *:

female:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Pneumonia
Renal failure acute (rapid kidney dysfunction)
Disease progression
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)

male:

Fatigue (feeling of tiredness)
Asthenia (weakness)
Blood albumin decreased
Constipation
Cough
Face oedema (swelling of face)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Headache (pain in head)
Hyperglycaemia (high blood sugar)
Mood altered (changes in mood)

What are the common drug interactions of Sunitinib Malate and Claritin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)

30-39:

n/a

40-49:

n/a

50-59:

Respiratory failure (inadequate gas exchange by the respiratory system)
Dizziness
Malaise (a feeling of general discomfort or uneasiness)

60+:

Fatigue (feeling of tiredness)
Asthenia (weakness)
Renal failure acute (rapid kidney dysfunction)
Asthma
Blood albumin decreased
Constipation
Cough
Disease progression
Face oedema (swelling of face)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 46.15%
Insomnia (sleeplessness): 4 people, 30.77%
Renal Cell Carcinoma (a kidney cancer): 4 people, 30.77%
Pain: 4 people, 30.77%
Osteoporosis (bones weak and more likely to break): 4 people, 30.77%
Nausea (feeling of having an urge to vomit): 4 people, 30.77%
Gastritis (inflammation of stomach): 4 people, 30.77%
Itching: 4 people, 30.77%
Spinal Osteoarthritis (joint cartilage loss in spine): 4 people, 30.77%
Hepatic Neoplasm Malignant (liver cancer): 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Sunitinib malate and Claritin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously